Articolul precedent |
Articolul urmator |
272 1 |
Ultima descărcare din IBN: 2021-03-25 14:22 |
SM ISO690:2012 CRANGACI, Marin. Afectarea sistemului gastrointestinal în maladiile reumatice. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 210. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 210-210 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. Rheumatic diseases represent a diverse group of illnesses that frequently affect the gastrointestinal tract. The manifestations of the G.I. symptoms are depending on the involved organ, as well as the base disease. Even if the majority of G.I. symptoms are uncommon they can lead to serious injuries. Objective of the study. The study of the gastrointestinal system affections in patients with rheumatic diseases, analysis of the frequency of major changes, and assessment of their severity degree in conformity with the rheumatic disease. Material and Methods. A descriptive study was conducted, retrospectively on a group of 60 patients diagnosed with rheumatic diseases in the IMSP SCR. All subjects met the ACR diagnostic criteria on RA, SLE, SyS. Patients were divided into 3 groups. I-st. group–20 patients with RA; II-nd. group–20 patients with SLE; III-rd. group–20 patients with SyS diffuse form. Results. It has been observed that the affection of the gastrointestinal system was present in 94% of patients with SyS, in 64% with SLE, not in all cases is registered the presence of the clinical symptoms, they are asymptomatic. Gastrointestinal manifestations of (RA) are rare (45%), some gastrointestinal processes are directly related to RA, meanwhile, others can be sequelae of treatment or caused by concomitant autoimmune diseases (autoimmune hepatitis - 4 patients (20%)). Conclusion. G.I. system affection occurs in rheumatic diseases as a result of the treatment with SMARD/DMARD, and as a manifestation of the underlying disease. Preventing complications from the G.I. system can be done through adequate management and investigation of the patient. |
||||||
Cuvinte-cheie rheumatoid arthritis, systemic lupus erythematosus, systemic scleroder, artrita reumatoidă, lupus eritematos sistemic, sclerodermie sistemică |
||||||
|